HK
MDGL icon

Horizon Kinetics’s Madrigal Pharmaceuticals MDGL Stock Holding History

Horizon Kinetics’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-514
Closed -$5K – 514
2016
Q2 		$5K Hold
514
– – ﹤0.01% 520
2016
Q1 		$4K Hold
514
– – ﹤0.01% 528
2015
Q4 		$6K Hold
514
– – ﹤0.01% 507
2015
Q3 		$31K Buy
514
+57
+12% +$4.11K ﹤0.01% 499
2015
Q2 		$36K Hold
457
– – ﹤0.01% 515
2015
Q1 		$31K Buy
457
+143
+46% +$12.3K ﹤0.01% 517
2014
Q4 		$29K Hold
314
– – ﹤0.01% 517
2014
Q3 		$33K Hold
314
– – ﹤0.01% 519
2014
Q2 		$45K Hold
314
– – ﹤0.01% 528
2014
Q1 		$47K Buy
+314
New +$61.8K ﹤0.01% 531

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return